A study of usefulness of fecal microbiota transplantation for refractory Clostridium difficile infection

A study of usefulness of fecal microbiota transplantation for refractory Clostridium difficile infection - A study of usefulness of fecal microbiota transplantation for refractory Clostridium difficile infection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018731

Enrollment

Registered

2015-09-01

Start date

2015-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reccurent Clostridium difficile infection

Interventions

infusion of solusion of donor feces to recipient&#39

s intestine.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Recurrent C. difficile infection even with enough treatment, i.e. vancomycin or metronidazole for more than 10 days.

Exclusion criteria

Exclusion criteria: 1) Receiving other antibiotics for C. difficile infection. 2) Receiving prednisolone 60 mg/day or more. 3) Complication of Severe infection. 4) Complication of mental desease. 5) Pregnant and nursing women

Design outcomes

Primary

Measure	Time frame
Relapse rate of C. difficile infection within 10 weeks after FMT.	—

Secondary

Measure	Time frame
change of diarrhea,disappearance of CD toxin,change of intestinal flora,relationship between donar and recipient intestinal flora,adverse event,relapse rate within 6 months.	—

Countries

Japan

Contacts

Public ContactTsunaki Sawada

Nagoya University Graduate School of Medicine Department of Gastroenterology and Hepatology

t.sawada@med.nagoya-u.ac.jp+81-52-741-2172

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026